Dr Heather Leigh Callum, MD | |
508 Upland St, Kenai, AK 99611-8026 | |
(907) 335-7510 | |
(888) 491-3360 |
Full Name | Dr Heather Leigh Callum |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 508 Upland St, Kenai, Alaska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083606461 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | D0050681 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Heather Leigh Callum, MD 508 Upland St, Kenai, AK 99611-8026 Ph: (907) 335-7510 | Dr Heather Leigh Callum, MD 508 Upland St, Kenai, AK 99611-8026 Ph: (907) 335-7510 |
News Archive
Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents, and Avila Therapeutics, Inc., a biotechnology company designing targeted covalent drugs, announced today an agreement for the development and commercialization of Avila's epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) program, currently in pre-clinical development for the treatment of non-small cell lung cancer (NSCLC).
Four researchers from Detroit, Michigan's Barbara Ann Karmanos Cancer Institute and Wayne State University will receive a total of $1.2 million from Susan G. Komen for the Cure to help advance research to better detect, prevent and eliminate breast cancer. The $1.2 million awarded to these outstanding scientists is part of the $59 million portfolio of research grants that Susan G. Komen for the Cure has awarded this year alone to scientists across the globe to help accelerate innovative breast cancer research.
Researchers at the University of Cincinnati have found that the race and sex of study personnel can influence a patient's decision on whether or not to participate in clinical research.
The US National Institutes of Health (NIH) has awarded a $2.1 million "Grand Opportunity" (GO) grant to a team of researchers - led by Prof. Todd Lencz at the Feinstein Institute for Medical Research, New York, and Prof.Ariel Darvasi of the Silberman Institute of Life Sciences at the Hebrew University of Jerusalem - to conduct a study on the genetic basis of schizophrenia..
› Verified 6 days ago
Michael K Visick, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 506 Lake St, Kenai, AK 99611 Phone: 907-714-4111 Fax: 844-412-3952 |